Furthermore, we found increased collagen deposition, as indicated by the elevated expression levels of α-SMA and COL1A1, this is consistent with the results of previous studies [37], and which were significantly alleviated by PFD and CEP administration. This evidence concerns the gene ACTA1 and polyostotic fibrous dysplasia.